CBD Life Sciences Inc. Secures Major CBD Beverage Order from Bronx Dispensary
Bronx, Tuesday, 14 October 2025.
CBD Life Sciences Inc. has received a significant order from Smoking Scholars, a Bronx dispensary, for its CBD-infused drinks. This development is expected to drive substantial revenue growth in the CBD beverage market.
Landmark Order from Smoking Scholars
CBD Life Sciences Inc. (OTC: CBDL) has secured a major order from Smoking Scholars, a prominent dispensary located in the Bronx, New York. This order includes an array of their CBD-infused beverages, featuring products like the 16oz 50mg CBD Lemonade, 16oz 25mg CBD Raspberry Lemonade, and 16oz 25mg CBD Lavender Lemonade, along with CBD-Infused Water [1][2]. This development is pivotal as it reflects a growing consumer interest in CBD beverages, particularly in a competitive market like New York City, which is known for its dynamic retail landscape [1].
Market Implications and Revenue Potential
The order from Smoking Scholars is expected to significantly enhance CBD Life Sciences Inc.’s revenue, with projections indicating potential six-figure monthly sales through bulk beverage orders [1][2]. This surge in demand aligns with broader market trends, as the CBD beverage market is projected to exceed $4.2 billion by 2030, driven by a compound annual growth rate (CAGR) of over 25% [1]. The company’s strategic positioning in the Bronx, one of the most lucrative retail markets in the United States, underscores its ambition to lead in the CBD industry [1].
Strategic Partnerships and Industry Expansion
The partnership with Smoking Scholars was facilitated through networking efforts at the NECANN Cannabis Conference, held on October 7, 2025, which opened doors to multiple partnership leads [2]. CBD Life Sciences Inc. is also actively negotiating with additional retailers and dispensaries across New Jersey and Pennsylvania, aiming to expand their regional footprint [1][2]. This strategic expansion is crucial as it fosters a robust pipeline of future sales and distribution opportunities, further establishing CBDL as a key player in the hemp-derived wellness product sector [1].
The Future of CBDL’s Beverage Division
The recent developments signal explosive growth for CBD Life Sciences Inc.’s CBD-infused drinks division, with the Bronx order setting the stage for potentially record-breaking revenue in the fourth quarter of 2025 and beyond [1][3]. The exceptional flavor, clean ingredients, and consistent dosage of their products have contributed to strong customer retention and retailer reorders [2]. As CEO Lisa Nelson stated, CBDL is not just participating in the CBD market but is leading a movement that promises to redefine the industry standards [2].